Long-term safety and disease control with ruxolitinib cream among patients with atopic dermatitis based on previous medication history: Pooled results from two phase 3 studies. J of Skin [Internet]. 2021 Nov. 5 [cited 2025 Apr. 18];5(6):s65. Available from: https://skin.dermsquared.com/skin/article/view/1416